vs
博士伦（BLCO）与GEO GROUP INC（GEO）财务数据对比。点击上方公司名可切换其他公司
博士伦的季度营收约是GEO GROUP INC的2.0倍（$1.4B vs $708.4M），GEO GROUP INC净利率更高（4.5% vs -4.1%，领先8.6%），GEO GROUP INC同比增速更快（16.6% vs 9.8%），博士伦自由现金流更多（$60.0M vs $-153.6M），过去两年博士伦的营收复合增速更高（13.1% vs 8.1%）
博士伦是知名眼健康产品企业，总部位于加拿大安大略省沃恩市，是全球规模最大的隐形眼镜、镜片护理产品、眼科药品、人工晶体及其他眼科手术产品供应商之一。品牌1853年由验光师约翰·鲍什与合伙人亨利·朗姆在美国纽约罗切斯特创立，曾是美国历史最悠久的持续运营企业之一，2013年被整体收购。
GEO集团是一家总部位于美国佛罗里达州博卡拉顿的上市企业，核心业务为投资及运营私营监狱、心理健康相关机构，业务覆盖美国、澳大利亚、南非、英国等市场，运营设施包含移民拘留中心、低安保级别拘留中心、心理健康及 residential 治疗机构，同时也承接政府所有设施的委托管理服务。
BLCO vs GEO — 直观对比
营收规模更大
BLCO
是对方的2.0倍
$708.4M
营收增速更快
GEO
高出6.8%
9.8%
净利率更高
GEO
高出8.6%
-4.1%
自由现金流更多
BLCO
多$213.6M
$-153.6M
两年增速更快
BLCO
近两年复合增速
8.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $708.4M |
| 净利润 | $-58.0M | $31.8M |
| 毛利率 | — | — |
| 营业利润率 | 8.0% | 11.8% |
| 净利率 | -4.1% | 4.5% |
| 营收同比 | 9.8% | 16.6% |
| 净利润同比 | -1833.3% | 105.1% |
| 每股收益（稀释后） | $-0.16 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLCOGEO
| Q4 25 | $1.4B | $708.4M | ||
| Q3 25 | $1.3B | $682.3M | ||
| Q2 25 | $1.3B | $636.2M | ||
| Q1 25 | $1.1B | $604.6M | ||
| Q4 24 | $1.3B | $607.7M | ||
| Q3 24 | $1.2B | $603.1M | ||
| Q2 24 | $1.2B | $607.2M | ||
| Q1 24 | $1.1B | $605.7M |
净利润BLCOGEO
| Q4 25 | $-58.0M | $31.8M | ||
| Q3 25 | $-28.0M | $173.9M | ||
| Q2 25 | $-62.0M | $29.1M | ||
| Q1 25 | $-212.0M | $19.6M | ||
| Q4 24 | $-3.0M | $15.5M | ||
| Q3 24 | $4.0M | $26.3M | ||
| Q2 24 | $-151.0M | $-32.5M | ||
| Q1 24 | $-167.0M | $22.7M |
营业利润率BLCOGEO
| Q4 25 | 8.0% | 11.8% | ||
| Q3 25 | 7.4% | 6.0% | ||
| Q2 25 | -0.9% | 11.3% | ||
| Q1 25 | -7.3% | 10.1% | ||
| Q4 24 | 6.8% | 11.2% | ||
| Q3 24 | 3.6% | 13.7% | ||
| Q2 24 | 2.1% | 13.2% | ||
| Q1 24 | 0.5% | 13.1% |
净利率BLCOGEO
| Q4 25 | -4.1% | 4.5% | ||
| Q3 25 | -2.2% | 25.5% | ||
| Q2 25 | -4.9% | 4.6% | ||
| Q1 25 | -18.6% | 3.2% | ||
| Q4 24 | -0.2% | 2.5% | ||
| Q3 24 | 0.3% | 4.4% | ||
| Q2 24 | -12.4% | -5.4% | ||
| Q1 24 | -15.2% | 3.7% |
每股收益（稀释后）BLCOGEO
| Q4 25 | $-0.16 | $0.16 | ||
| Q3 25 | $-0.08 | $1.24 | ||
| Q2 25 | $-0.18 | $0.21 | ||
| Q1 25 | $-0.60 | $0.21 | ||
| Q4 24 | $-0.00 | $0.14 | ||
| Q3 24 | $0.01 | $0.19 | ||
| Q2 24 | $-0.43 | $-0.25 | ||
| Q1 24 | $-0.48 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $383.0M | $69.0M |
| 总债务越低越好 | $5.0B | $1.7B |
| 股东权益账面价值 | $6.4B | $1.5B |
| 总资产 | $14.0B | $3.8B |
| 负债/权益比越低杠杆越低 | 0.78× | 1.11× |
8季度趋势，按日历期对齐
现金及短期投资BLCOGEO
| Q4 25 | $383.0M | $69.0M | ||
| Q3 25 | $310.0M | $183.9M | ||
| Q2 25 | $266.0M | $67.9M | ||
| Q1 25 | $202.0M | $64.8M | ||
| Q4 24 | $305.0M | $76.9M | ||
| Q3 24 | $329.0M | $70.6M | ||
| Q2 24 | $285.0M | $46.3M | ||
| Q1 24 | $315.0M | $126.5M |
总债务BLCOGEO
| Q4 25 | $5.0B | $1.7B | ||
| Q3 25 | $5.0B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $4.8B | — | ||
| Q4 24 | $4.8B | $1.7B | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — | ||
| Q1 24 | $4.6B | — |
股东权益BLCOGEO
| Q4 25 | $6.4B | $1.5B | ||
| Q3 25 | $6.4B | $1.5B | ||
| Q2 25 | $6.4B | $1.4B | ||
| Q1 25 | $6.4B | $1.3B | ||
| Q4 24 | $6.5B | $1.3B | ||
| Q3 24 | $6.6B | $1.3B | ||
| Q2 24 | $6.5B | $1.3B | ||
| Q1 24 | $6.7B | $1.3B |
总资产BLCOGEO
| Q4 25 | $14.0B | $3.8B | ||
| Q3 25 | $13.8B | $3.8B | ||
| Q2 25 | $13.8B | $3.7B | ||
| Q1 25 | $13.4B | $3.6B | ||
| Q4 24 | $13.5B | $3.6B | ||
| Q3 24 | $13.5B | $3.6B | ||
| Q2 24 | $13.3B | $3.6B | ||
| Q1 24 | $13.3B | $3.7B |
负债/权益比BLCOGEO
| Q4 25 | 0.78× | 1.11× | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | 0.77× | — | ||
| Q1 25 | 0.76× | — | ||
| Q4 24 | 0.74× | 1.31× | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.69× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $136.0M | $-117.3M |
| 自由现金流经营现金流 - 资本支出 | $60.0M | $-153.6M |
| 自由现金流率自由现金流/营收 | 4.3% | -21.7% |
| 资本支出强度资本支出/营收 | 5.4% | 5.1% |
| 现金转化率经营现金流/净利润 | — | -3.69× |
| 过去12个月自由现金流最近4个季度 | $-66.0M | $-124.9M |
8季度趋势，按日历期对齐
经营现金流BLCOGEO
| Q4 25 | $136.0M | $-117.3M | ||
| Q3 25 | $137.0M | $79.6M | ||
| Q2 25 | $35.0M | $39.2M | ||
| Q1 25 | $-25.0M | $71.2M | ||
| Q4 24 | $22.0M | $18.5M | ||
| Q3 24 | $154.0M | $109.3M | ||
| Q2 24 | $15.0M | $31.2M | ||
| Q1 24 | $41.0M | $83.3M |
自由现金流BLCOGEO
| Q4 25 | $60.0M | $-153.6M | ||
| Q3 25 | $63.0M | $-14.1M | ||
| Q2 25 | $-54.0M | $2.4M | ||
| Q1 25 | $-135.0M | $40.5M | ||
| Q4 24 | $-70.0M | $-2.3M | ||
| Q3 24 | $94.0M | $90.5M | ||
| Q2 24 | $-57.0M | $6.8M | ||
| Q1 24 | $-26.0M | $68.5M |
自由现金流率BLCOGEO
| Q4 25 | 4.3% | -21.7% | ||
| Q3 25 | 4.9% | -2.1% | ||
| Q2 25 | -4.2% | 0.4% | ||
| Q1 25 | -11.9% | 6.7% | ||
| Q4 24 | -5.5% | -0.4% | ||
| Q3 24 | 7.9% | 15.0% | ||
| Q2 24 | -4.7% | 1.1% | ||
| Q1 24 | -2.4% | 11.3% |
资本支出强度BLCOGEO
| Q4 25 | 5.4% | 5.1% | ||
| Q3 25 | 5.8% | 13.7% | ||
| Q2 25 | 7.0% | 5.8% | ||
| Q1 25 | 9.7% | 5.1% | ||
| Q4 24 | 7.2% | 3.4% | ||
| Q3 24 | 5.0% | 3.1% | ||
| Q2 24 | 5.9% | 4.0% | ||
| Q1 24 | 6.1% | 2.4% |
现金转化率BLCOGEO
| Q4 25 | — | -3.69× | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 1.35× | ||
| Q1 25 | — | 3.64× | ||
| Q4 24 | — | 1.19× | ||
| Q3 24 | 38.50× | 4.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLCO
| Overthe Counter Products | $489.0M | 35% |
| Pharmaceuticals | $378.0M | 27% |
| Other | $263.0M | 19% |
| Surgical | $249.0M | 18% |
| Brandedand Other Generic Products | $14.0M | 1% |
| Other Revenues | $3.0M | 0% |
| Pharmaceutical Products | $2.0M | 0% |
GEO
| Us Corrections And Detention | $498.0M | 70% |
| Electronic Monitoring And Supervision Services | $83.7M | 12% |
| Reentry Services | $72.2M | 10% |
| AU | $49.1M | 7% |
| ZA | $5.4M | 1% |
